Marion Dorsch, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 2,300 shares at $70.00 ($162K) on 2018-09-17, disclosed to the SEC on 2018-09-19.
Open-market sale of $162k BPMC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.00 | 1,700 | $119K | 73.4% |
| 2 | $70.59 | 300 | $21K | 13.1% |
| 3 | $73.05 | 300 | $22K | 13.5% |
| Total | $70.47 avg | 2,300 | $162K | 100% |
| Filing → |
| BPMC | SELL | 2020-10-08 | $455K | — | Filing → |
| BPMC | SELL | 2020-09-25 | $409K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $363K | — | Filing → |